drugset / Trial / NCT00691886

Safety and Efficacy of Intravenous (IV) Dexmedetomidine During Flexible Bronchoscopy and Endobronchial Ultrasound

NCT00691886 ↗

Phase 4 Withdrawn Lahey Clinic
RandomizedParallel-groupOpen-labelSupportive care

Summary

To achieve safe,consistent, continuous sedation using Dexmedetomidine in advaced bronchoscopy procedures that may reduce the need for rapid pain sedative infusion.

Timeline

Start
2008-04
Primary completion
2012-07
Completion
2012-07

Outcome

Outcome not reported

Stopped (Enrollment): “PI left institution prior to enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.4 ug/kg Intravenous
Comparator Dexmedetomidine Other / unclassified 1.5 ug/kg Intravenous

Indications

No indication recorded.